Applying AHK-CU before bed means the peptide is present when your follicles are most active in their regeneration processes
A 90kg researcher who tolerates 4mg easily might escalate to 8mg sooner than a 60kg researcher who experiences significant appetite suppression at 4mg
(Midi does not prescribe this or other unapproved peptides.) What the science says: As of now, there have been no human clinical trials testing TB-500
The two settlements and one complaint, filed in U.S
prescription drugs by sales are largely expensive, specialized therapies (often biologics) for serious chronic illnesses (cancer, diabetes/obesity, autoimmune disease, etc.)
The retinoid comparison makes GHK-Cu discontinuation appear favorable since copper peptide cessation typically produces gradual benefit decline without rebound worsening or dramatic rapid reversal